Delivering externally manufactured cell and gene therapy products to patients: perspectives from the academic center experience.
Sign Up to like & getrecommendations! Published in 2021 at "Cytotherapy"
DOI: 10.1016/j.jcyt.2021.09.010
Abstract: The recent success of the commercialization of CAR-T and other immune effector cells has led to the rapid expansion of clinical trials using cellular therapy products. The expansion of both investigational and commercially available cell… read more here.
Keywords: center; externally manufactured; therapy products; therapy ... See more keywords